Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» $35M deal: Incyte licenses Lilly drug for potential new use
$35M deal: Incyte licenses Lilly drug for potential new use
$35M deal: Incyte licenses Lilly drug for potential new use
Submitted by
admin
on April 6, 2016 - 10:20pm
Source:
Bizjournals.com
News Tags:
Incyte
Eli Lilly
ruxolitinib
graft vs host disease
Headline:
$35M deal: Incyte licenses Lilly drug for potential new use
Do Not Allow Advertisers to Use My Personal information
